Company Description

Mobius Therapeutics, a Glaukos company, is a commercial stage venture focused upon perioperative sterile injectables used in ophthalmic surgery. Its first product, Mitosol, is the only FDA approved formulation of mitomycin-c bearing an ophthalmic indication.